New therapeutic approaches for influenza A H5N1 infected humans.
Ward
Peter A
PA
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000502:physiology; D007251:Influenza, Human / Q000188:drug therapy* / Q000821:virology; D008168:Lung / Q000821:virology; D011486:Protein C / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014779:Virus Replication
D005343:Fibrinolytic Agents; D011486:Protein C; D014409:Tumor Necrosis Factor-alpha